Seeking stellar students, postdocs and scientists interested in making a difference in #braintumor and #immunotherapy, #CARTcell. Kicking off my lab @MGHNeurosurg. Please share or reach out for more info!
Today, @NEJM published our clinical study of a novel #CARTCell in patients with #Glioblastoma. Early results with CARv3-TEAM-E suggest safety and bioactivity. Special thanks to all collaborators @MGHNeurosurg and @MGHCancerCenter!
nej.md/3VnjUIq
Significant responses to GD2 CAR T cells in multiple patients with diffuse midline glioma, reported by our colleagues @Stanford in @Nature today. Congrats @michelle_monje and co-authors for this giant leap forward in our field!
nature.com/articles/s4158…
Our first preclinical description of this therapeutic strategy was published in @NatureBiotech less than 5 years ago. Excited for this bench-to-bedside story.
doi.org/10.1038/s41587…